Remyelination in multiple sclerosis: from basic science to clinical translation

Thompson, 2018, Multiple sclerosis, Lancet, 391, 1622, 10.1016/S0140-6736(18)30481-1 Friese, 2014, Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis, Nat Rev Neurol, 10, 225, 10.1038/nrneurol.2014.37 Singh, 2017, Relationship of acute axonal damage, Wallerian degeneration, and clinical disability in multiple sclerosis, J Neuroinflammation, 14, 57, 10.1186/s12974-017-0831-8 Nasrabady, 2018, White matter changes in Alzheimer's disease: a focus on myelin and oligodendrocytes, Acta Neuropathol Commun, 6, 22, 10.1186/s40478-018-0515-3 Caso, 2016, Insights into white matter damage in Alzheimer's disease: from postmortem to in vivo diffusion tensor MRI studies, Neurodegenerative Diseases, 16, 26, 10.1159/000441422 Rajani, 2018, Reversal of endothelial dysfunction reduces white matter vulnerability in cerebral small vessel disease in rats, Sci Transl Med, 10, 10.1126/scitranslmed.aam9507 Fünfschilling, 2012, Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity, Nature, 485, 517, 10.1038/nature11007 Saab, 2017, Myelin dynamics: protecting and shaping neuronal functions, Curr Opin Neurobiol, 47, 104, 10.1016/j.conb.2017.09.013 Lee, 2012, Oligodendroglia metabolically support axons and contribute to neurodegeneration, Nature, 487, 443, 10.1038/nature11314 Schirmer, 2018, Oligodendrocyte-encoded Kir4.1 function is required for axonal integrity, eLife, 7, 10.7554/eLife.36428 Larson, 2018, Oligodendrocytes control potassium accumulation in white matter and seizure susceptibility, eLife, 7, 10.7554/eLife.34829 Dendrou, 2015, Immunopathology of multiple sclerosis, Nat Rev Immunol, 15, 545, 10.1038/nri3871 Waxman, 2004, Na+ channel expression along axons in multiple sclerosis and its models, Trends Pharmacol Sci, 25, 584, 10.1016/j.tips.2004.09.001 Schirmer, 2014, Differential loss of KIR4.1 immunoreactivity in multiple sclerosis lesions, Ann Neurol, 75, 810, 10.1002/ana.24168 Schultz, 2017, Acutely damaged axons are remyelinated in multiple sclerosis and experimental models of demyelination, Glia, 65, 1350, 10.1002/glia.23167 Kornek, 2000, Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions, Am J Pathol, 157, 267, 10.1016/S0002-9440(10)64537-3 Lassmann, 2017, Multiple sclerosis: experimental models and reality, Acta Neuropathol, 133, 223, 10.1007/s00401-016-1631-4 Irvine, 2008, Remyelination protects axons from demyelination-associated axon degeneration, Brain, 131, 1464, 10.1093/brain/awn080 Mei, 2016, Accelerated remyelination during inflammatory demyelination prevents axonal loss and improves functional recovery, eLife, 5, 10.7554/eLife.18246 Duncan, 2009, Extensive remyelination of the CNS leads to functional recovery, Proc Natl Acad Sci USA, 106, 6832, 10.1073/pnas.0812500106 Chang, 2012, Cortical remyelination: a new target for repair therapies in multiple sclerosis, Ann Neurol, 72, 918, 10.1002/ana.23693 Battefeld, 2016, Myelinating satellite oligodendrocytes are integrated in a glial syncytium constraining neuronal high-frequency activity, Nat Commun, 7, 10.1038/ncomms11298 Manrique-Hoyos, 2012, Late motor decline after accomplished remyelination: impact for progressive multiple sclerosis, Ann Neurol, 71, 227, 10.1002/ana.22681 Chen, 2008, Magnetization transfer ratio evolution with demyelination and remyelination in multiple sclerosis lesions, Ann Neurol, 63, 254, 10.1002/ana.21302 Brown, 2014, Imaging of repeated episodes of demyelination and remyelination in multiple sclerosis, Neuroimage Clin, 6, 20, 10.1016/j.nicl.2014.06.009 Petiet, 2019, Ultrahigh field imaging of myelin disease models: toward specific markers of myelin integrity?, J Comp Neurol, 527, 2179, 10.1002/cne.24598 Fujiyoshi, 2016, Application of q-space diffusion MRI for the visualization of white matter, J Neurosci, 36, 2796, 10.1523/JNEUROSCI.1770-15.2016 Stankoff, 2011, Imaging central nervous system myelin by positron emission tomography in multiple sclerosis using [methyl-11C]-2-(4′-methylaminophenyl)- 6-hydroxybenzothiazole, Ann Neurol, 69, 673, 10.1002/ana.22320 Wu, 2013, Longitudinal positron emission tomography imaging for monitoring myelin repair in the spinal cord, Ann Neurol, 74, 688, 10.1002/ana.23965 Bodini, 2016, Dynamic imaging of individual remyelination profiles in multiple sclerosis, Ann Neurol, 79, 726, 10.1002/ana.24620 Franklin, 2017, Regenerating CNS myelin—from mechanisms to experimental medicines, Nat Rev Neurosci, 18, 753, 10.1038/nrn.2017.136 Zawadzka, 2010, CNS-resident glial progenitor/stem cells produce Schwann cells as well as oligodendrocytes during repair of CNS demyelination, Cell Stem Cell, 6, 578, 10.1016/j.stem.2010.04.002 Piaton, 2011, Class 3 semaphorins influence oligodendrocyte precursor recruitment and remyelination in adult central nervous system, Brain, 134, 1156, 10.1093/brain/awr022 Boyd, 2013, Insufficient OPC migration into demyelinated lesions is a cause of poor remyelination in MS and mouse models, Acta Neuropathol, 125, 841, 10.1007/s00401-013-1112-y Xing, 2014, Adult neural precursor cells from the subventricular zone contribute significantly to oligodendrocyte regeneration and remyelination, J Neurosci, 34, 14128, 10.1523/JNEUROSCI.3491-13.2014 Remaud, 2017, Transient hypothyroidism favors oligodendrocyte generation providing functional remyelination in the adult mouse brain, eLife, 6, 10.7554/eLife.29996 Duncan, 2018, The adult oligodendrocyte can participate in remyelination, Proc Natl Acad Sci USA, 115, e11807, 10.1073/pnas.1808064115 Lubetzki, 1988, Myelination by oligodendrocytes isolated from 4–6-week-old rat central nervous system and transplanted into newborn shiverer brain, J Neurol Sci, 88, 161, 10.1016/0022-510X(88)90214-6 Périer, 1965, Electron microscopic features of multiple sclerosis lesions, Brain, 88, 937, 10.1093/brain/88.5.937 Prineas, 1979, Remyelination in multiple sclerosis, Ann Neurol, 5, 22, 10.1002/ana.410050105 Chang, 2002, Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis, N Engl J Med, 346, 165, 10.1056/NEJMoa010994 Bunge, 1961, Ultrastructural study of remyelination in an experimental lesion in adult cat spinal cord, J Biophys Biochem Cytol, 10, 67, 10.1083/jcb.10.1.67 Blakemore, 1974, Pattern of remyelination in the CNS, Nature, 249, 577, 10.1038/249577a0 Neumann, 2020, Problems and pitfalls of identifying remyelination in multiple sclerosis, Cell Stem Cell, 26, 617, 10.1016/j.stem.2020.03.017 Schmierer, 2004, Magnetization transfer ratio and myelin in postmortem multiple sclerosis brain, Ann Neurol, 56, 407, 10.1002/ana.20202 Fard, 2017, BCAS1 expression defines a population of early myelinating oligodendrocytes in multiple sclerosis lesions, Sci Transl Med, 9, 10.1126/scitranslmed.aam7816 Nait-Oumesmar, 2007, Activation of the subventricular zone in multiple sclerosis: evidence for early glial progenitors, Proc Natl Acad Sci USA, 104, 4694, 10.1073/pnas.0606835104 Yeung, 2014, Dynamics of oligodendrocyte generation and myelination in the human brain, Cell, 159, 766, 10.1016/j.cell.2014.10.011 Yeung, 2019, Dynamics of oligodendrocyte generation in multiple sclerosis, Nature, 566, 538, 10.1038/s41586-018-0842-3 Jäkel, 2019, Altered human oligodendrocyte heterogeneity in multiple sclerosis, Nature, 566, 543, 10.1038/s41586-019-0903-2 Moyon, 2015, Demyelination causes adult CNS progenitors to revert to an immature state and express immune cues that support their migration, J Neurosci, 35, 4, 10.1523/JNEUROSCI.0849-14.2015 Stangel, 2017, Achievements and obstacles of remyelinating therapies in multiple sclerosis, Nat Rev Neurol, 13, 742, 10.1038/nrneurol.2017.139 Woodruff, 2004, Platelet-derived growth factor regulates oligodendrocyte progenitor numbers in adult CNS and their response following CNS demyelination, Mol Cell Neurosci, 25, 252, 10.1016/j.mcn.2003.10.014 Wang, 2007, Contrasting effects of mitogenic growth factors on myelination in neuron-oligodendrocyte co-cultures, Glia, 55, 537, 10.1002/glia.20480 Tepavčević, 2014, Early netrin-1 expression impairs central nervous system remyelination, Ann Neurol, 76, 252, 10.1002/ana.24201 Mathieu, 2019, Demyelination-remyelination in the central nervous system: ligand-dependent participation of the Notch signaling pathway, Toxicol Sci, 10.1093/toxsci/kfz130 Mi, 2005, LINGO-1 negatively regulates myelination by oligodendrocytes, Nat Neurosci, 8, 745, 10.1038/nn1460 Fancy, 2009, Dysregulation of the Wnt pathway inhibits timely myelination and remyelination in the mammalian CNS, Genes Dev, 23, 1571, 10.1101/gad.1806309 Dai, 2014, Stage-specific regulation of oligodendrocyte development by Wnt/β-catenin signaling, J Neurosci, 34, 8467, 10.1523/JNEUROSCI.0311-14.2014 Mei, 2014, Micropillar arrays as a high-throughput screening platform for therapeutics in multiple sclerosis, Nat Med, 20, 954, 10.1038/nm.3618 Back, 2005, Hyaluronan accumulates in demyelinated lesions and inhibits oligodendrocyte progenitor maturation, Nat Med, 11, 966, 10.1038/nm1279 Pu, 2018, The extracellular matrix: focus on oligodendrocyte biology and targeting CSPGs for remyelination therapies, Glia, 66, 1809, 10.1002/glia.23333 Petersen, 2017, Fibrinogen activates BMP signaling in oligodendrocyte progenitor cells and inhibits remyelination after vascular damage, Neuron, 96, 1003, 10.1016/j.neuron.2017.10.008 Segel, 2019, Niche stiffness underlies the ageing of central nervous system progenitor cells, Nature, 573, 130, 10.1038/s41586-019-1484-9 Huang, 2011, Retinoid X receptor gamma signaling accelerates CNS remyelination, Nat Neurosci, 14, 45, 10.1038/nn.2702 Hartley, 2019, Myelin repair stimulated by CNS-selective thyroid hormone action, JCI Insight, 4, 10.1172/jci.insight.126329 de la Fuente, 2015, Vitamin D receptor-retinoid X receptor heterodimer signaling regulates oligodendrocyte progenitor cell differentiation, J Cell Biol, 211, 975, 10.1083/jcb.201505119 Emery, 2015, Transcriptional and epigenetic regulation of oligodendrocyte development and myelination in the central nervous system, Cold Spring Harb Perspect Biol, 7, 10.1101/cshperspect.a020461 Ulc, 2019, The guanine nucleotide exchange factor Vav3 modulates oligodendrocyte precursor differentiation and supports remyelination in white matter lesions, Glia, 67, 376, 10.1002/glia.23548 Demerens, 1996, Induction of myelination in the central nervous system by electrical activity, Proc Natl Acad Sci USA, 93, 9887, 10.1073/pnas.93.18.9887 Stevens, 1998, Control of myelination by specific patterns of neural impulses, J Neurosci, 18, 9303, 10.1523/JNEUROSCI.18-22-09303.1998 Gibson, 2014, Neuronal activity promotes oligodendrogenesis and adaptive myelination in the mammalian brain, Science, 344, 10.1126/science.1252304 Koudelka, 2016, Individual neuronal subtypes exhibit diversity in CNS myelination mediated by synaptic vesicle release, Curr Biol, 26, 1447, 10.1016/j.cub.2016.03.070 Mitew, 2018, Pharmacogenetic stimulation of neuronal activity increases myelination in an axon-specific manner, Nat Commun, 9, 306, 10.1038/s41467-017-02719-2 Stedehouder, 2018, Activity-dependent myelination of parvalbumin interneurons mediated by axonal morphological plasticity, J Neurosci, 38, 3631, 10.1523/JNEUROSCI.0074-18.2018 Bergles, 2000, Glutamatergic synapses on oligodendrocyte precursor cells in the hippocampus, Nature, 405, 187, 10.1038/35012083 Wake, 2015, Nonsynaptic junctions on myelinating glia promote preferential myelination of electrically active axons, Nat Commun, 6, 10.1038/ncomms8844 Wake, 2011, Control of local protein synthesis and initial events in myelination by action potentials, Science, 333, 1647, 10.1126/science.1206998 Fields, 2015, A new mechanism of nervous system plasticity: activity-dependent myelination, Nat Rev Neurosci, 16, 756, 10.1038/nrn4023 Gautier, 2015, Neuronal activity regulates remyelination via glutamate signalling to oligodendrocyte progenitors, Nat Commun, 6, 10.1038/ncomms9518 Ortiz, 2019, Neuronal activity in vivo enhances functional myelin repair, JCI Insight, 5 Jensen, 2018, Multimodal enhancement of remyelination by exercise with a pivotal role for oligodendroglial PGC1α, Cell Rep, 24, 3167, 10.1016/j.celrep.2018.08.060 Lubetzki, 1993, Even in culture, oligodendrocytes myelinate solely axons, Proc Natl Acad Sci USA, 90, 6820, 10.1073/pnas.90.14.6820 Bechler, 2015, CNS myelin sheath lengths are an intrinsic property of oligodendrocytes, Curr Biol, 25, 2411, 10.1016/j.cub.2015.07.056 Bechler, 2018, Intrinsic and adaptive myelination—a sequential mechanism for smart wiring in the brain, Dev Neurobiol, 78, 68, 10.1002/dneu.22518 Bieber, 2003, Efficient central nervous system remyelination requires T cells, Ann Neurol, 53, 680, 10.1002/ana.10578 Dombrowski, 2017, Regulatory T cells promote myelin regeneration in the central nervous system, Nat Neurosci, 20, 674, 10.1038/nn.4528 Baxi, 2015, Transfer of myelin-reactive th17 cells impairs endogenous remyelination in the central nervous system of cuprizone-fed mice, J Neurosci, 35, 8626, 10.1523/JNEUROSCI.3817-14.2015 El Behi, 2017, Adaptive human immunity drives remyelination in a mouse model of demyelination, Brain, 140, 967, 10.1093/brain/awx008 Zrzavy, 2017, Loss of ‘homeostatic’ microglia and patterns of their activation in active multiple sclerosis, Brain, 140, 1900, 10.1093/brain/awx113 Peferoen, 2015, Activation status of human microglia is dependent on lesion formation stage and remyelination in multiple sclerosis, J Neuropathol Exp Neurol, 74, 48, 10.1097/NEN.0000000000000149 Ransohoff, 2016, A polarizing question: do M1 and M2 microglia exist?, Nat Neurosci, 19, 987, 10.1038/nn.4338 Stratoulias, 2019, Microglial subtypes: diversity within the microglial community, EMBO J, 38, 10.15252/embj.2019101997 Masuda, 2019, Spatial and temporal heterogeneity of mouse and human microglia at single-cell resolution, Nature, 566, 388, 10.1038/s41586-019-0924-x Kremer, 2019, pHERV-W envelope protein fuels microglial cell-dependent damage of myelinated axons in multiple sclerosis, Proc Natl Acad Sci USA, 116, 15216, 10.1073/pnas.1901283116 Kotter, 2001, Macrophage depletion impairs oligodendrocyte remyelination following lysolecithin-induced demyelination, Glia, 35, 204, 10.1002/glia.1085 Lloyd, 2019, The pro-remyelination properties of microglia in the central nervous system, Nat Rev Neurol, 15, 447, 10.1038/s41582-019-0184-2 Ruckh, 2012, Rejuvenation of regeneration in the aging central nervous system, Cell Stem Cell, 10, 96, 10.1016/j.stem.2011.11.019 Lloyd, 2019, Central nervous system regeneration is driven by microglia necroptosis and repopulation, Nat Neurosci, 22, 1046, 10.1038/s41593-019-0418-z Miron, 2017, Microglia-driven regulation of oligodendrocyte lineage cells, myelination, and remyelination, J Leukoc Biol, 101, 1103, 10.1189/jlb.3RI1116-494R Miron, 2013, M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination, Nat Neurosci, 16, 1211, 10.1038/nn.3469 Arnett, 2001, TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination, Nat Neurosci, 4, 1116, 10.1038/nn738 Cunha, 2020, Pro-inflammatory activation following demyelination is required for myelin clearance and oligodendrogenesis, J Exp Med, 217, 10.1084/jem.20191390 Nörenberg, 2011, Clemastine potentiates the human P2X7 receptor by sensitizing it to lower ATP concentrations, J Biol Chem, 286, 11067, 10.1074/jbc.M110.198879 Wang, 2015, Quetiapine inhibits microglial activation by neutralizing abnormal STIM1-mediated intercellular calcium homeostasis and promotes myelin repair in a cuprizone-induced mouse model of demyelination, Front Cell Neurosci, 9, 492, 10.3389/fncel.2015.00492 Deshmukh, 2013, A regenerative approach to the treatment of multiple sclerosis, Nature, 502, 327, 10.1038/nature12647 Najm, 2015, Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo, Nature, 522, 216, 10.1038/nature14335 Stankoff, 2002, Ciliary neurotrophic factor (CNTF) enhances myelin formation: a novel role for CNTF and CNTF-related molecules, J Neurosci, 22, 9221, 10.1523/JNEUROSCI.22-21-09221.2002 Mei, 2014, Micropillar arrays as a high-throughput screening platform for therapeutics in multiple sclerosis, Nat Med, 20, 954, 10.1038/nm.3618 Buckley, 2010, Drug reprofiling using zebrafish identifies novel compounds with potential pro-myelination effects, Neuropharmacology, 59, 149, 10.1016/j.neuropharm.2010.04.014 Mannioui, 2018, The Xenopus tadpole: an in vivo model to screen drugs favoring remyelination, Mult Scler, 24, 1421, 10.1177/1352458517721355 Hubler, 2018, Accumulation of 8,9-unsaturated sterols drives oligodendrocyte formation and remyelination, Nature, 560, 372, 10.1038/s41586-018-0360-3 Rankin, 2019, Selective estrogen receptor modulators enhance CNS remyelination independent of estrogen receptors, J Neurosci, 39, 2184, 10.1523/JNEUROSCI.1530-18.2019 Neumann, 2019, Metformin restores CNS remyelination capacity by rejuvenating aged stem cells, Cell Stem Cell, 25, 473, 10.1016/j.stem.2019.08.015 Diebold, 2019, The monoclonal antibody GNbAC1: targeting human endogenous retroviruses in multiple sclerosis, Ther Adv Neurol Disord, 12, 10.1177/1756286419833574 Schwartzbach, 2017, Lesion remyelinating activity of GSK239512 versus placebo in patients with relapsing-remitting multiple sclerosis: a randomised, single-blind, phase II study, J Neurol, 264, 304, 10.1007/s00415-016-8341-7 Cadavid, 2019, Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial, Lancet Neurol, 18, 845, 10.1016/S1474-4422(19)30137-1 Cadavid, 2017, Safety and efficacy of opicinumab in acute optic neuritis (RENEW): a randomised, placebo-controlled, phase 2 trial, Lancet Neurol, 16, 189, 10.1016/S1474-4422(16)30377-5 Green, 2017, Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial, Lancet, 390, 2481, 10.1016/S0140-6736(17)32346-2 Zhang, 2019, Evolution of clinical trials in multiple sclerosis, Ther Adv Neurol Disord, 12, 10.1177/1756286419826547